Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend BTIG’s MedTech, ...
BTIG Reaffirms Their Buy Rating on AeroVironment (AVAV)
In a report released yesterday, Andre Madrid from BTIG reiterated a Buy rating on AeroVironment (AVAV – Research Report), with a price target ...
RealReal price target raised to $9 from $6.75 at BTIG
BTIG raised the firm’s price target on RealReal (REAL) to $9 from $6.75 and keeps a Buy rating on the shares. The company’s better than ...
BTIG maintains Neutral on Kilroy Realty shares post-earnings
BTIG analyst Thomas Catherwood maintained a Neutral rating on shares of Kilroy Realty Corporation (NYSE:KRC), following the company's release of its fourth-quarter 2024 financial results. Kilroy ...
BTIG maintains Buy rating and $225 target on Zoetis shares
Tuesday, analysts at BTIG reaffirmed their positive stance on Zoetis Inc . (NYSE:ZTS), maintaining a Buy rating and a price target of $225.00. With analyst targets ranging from $178 to $243, BTIG's ...